Skip to content

Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation

Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation : a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02256358
Enrollment
68
Registered
2014-10-03
Start date
2013-01-31
Completion date
2014-01-31
Last updated
2014-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychomotor Agitation

Keywords

child, ketamine, midazolam

Brief summary

Compare the effects of intravenous midazolam and ketamine on emergence agitation after sevoflurane anesthesia

Detailed description

Emergence agitation is self-limiting aggressive behavior that develops in the early period of awakening from anesthesia. A high level of preoperative anxiety is a risk factor for emergence agitation using Aono's four-point scale. Midazolam and ketamine was administered to the patients to decrease of preoperative anxiety. We aimed to compare the emergence agitation between midazolam group and ketamine group.

Interventions

DRUGMidazolam

preoperatively injected intravenous 0.1 mg/kg midazolam

DRUGKetamine

Preoperatively injected intravenous 1mg/kg ketamine

Sponsors

Inje University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* American society of anesthesiologists physical status 1-2 aged 2-6 years old, who were scheduled to undergo ophthalmic surgery (\<2hr)

Exclusion criteria

* children with central nervous system disorders,history of allergy to the study drugs (midazolam and ketamine), history of recent respiratory tract infection

Design outcomes

Primary

MeasureTime frameDescription
Emergence AgitationDuring 30 minutes after extubation at post-anesthetic care unit, every 5 minutesThe primary endpoint is the incidence of postoperative emergence agitation that was defined as an Aono's four-point scale(AFPS) score of 3 or higher.

Participant flow

Participants by arm

ArmCount
Midazolam
Intravenous 0.1 mg/kg midazolam was administered to the patients as premedication drug before entering operating room. Midazolam: preoperatively injected intravenous 0.1 mg/kg midazolam
34
Ketamine
Intravenous 1 mg/kg ketamine was administered to the patients as premedication drug before entering operating room. Ketamine: Preoperatively injected intravenous 1mg/kg ketamine
33
Total67

Baseline characteristics

CharacteristicMidazolamKetamineTotal
Age, Continuous4.15 year
STANDARD_DEVIATION 1.4
4.21 year
STANDARD_DEVIATION 1.32
4.18 year
STANDARD_DEVIATION 1.35
Sex: Female, Male
Female
18 Participants17 Participants35 Participants
Sex: Female, Male
Male
16 Participants16 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 340 / 34
serious
Total, serious adverse events
0 / 340 / 34

Outcome results

Primary

Emergence Agitation

The primary endpoint is the incidence of postoperative emergence agitation that was defined as an Aono's four-point scale(AFPS) score of 3 or higher.

Time frame: During 30 minutes after extubation at post-anesthetic care unit, every 5 minutes

ArmMeasureValue (NUMBER)
MidazolamEmergence Agitation6 participants
KetamineEmergence Agitation0 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026